Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion type Assertion NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_head.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion description "[The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_provenance.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion evidence source_evidence_literature NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_provenance.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion SIO_000772 25135238 NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_provenance.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion wasDerivedFrom befree-2016 NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_provenance.
- NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_assertion wasGeneratedBy ECO_0000203 NP1211757.RATGG6-I167RqgO8EqJt9MMwssUKEiLwXwygo2t-Kbq2Q130_provenance.